VERACYTE, INC. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
VERACYTE, INC. (VCYT) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $4.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-31
- VERACYTE, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $4.29M, a 80.34% increase year-over-year.
- VERACYTE, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $9.36M, a 0.92% decline year-over-year.
- VERACYTE, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-12-31 was $3.66M, a 11.76% increase year-over-year.
- VERACYTE, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $2.81M, a 28.96% increase year-over-year.
- VERACYTE, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $18.30M, a 72.86% increase from fiscal 2024.
- VERACYTE, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $10.59M, a 57.08% increase from fiscal 2023.
- VERACYTE, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $6.74M, a 112.85% increase from fiscal 2022.
- VERACYTE, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $3.17M, a 64.92% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.29M 10-Q · filed 2026-07-31 | $13.66M 10-Q · filed 2026-07-31 | $17.32M derived: sum of 3 quarters · filed 2026-07-31 | $20.13M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $9.36M 10-Q · filed 2026-05-06 | $13.02M derived: sum of 2 quarters · filed 2026-05-06 | $15.84M derived: sum of 3 quarters · filed 2026-05-06 | $18.22M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.47M derived: sum of 2 quarters · filed 2026-02-26 | $8.85M derived: sum of 3 quarters · filed 2026-07-31 | $18.30M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.81M 10-Q · filed 2025-11-05 | $5.20M derived: sum of 2 quarters · filed 2026-07-31 | $14.64M 10-Q · filed 2025-11-05 | $17.92M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $2.38M 10-Q · filed 2026-07-31 | $11.83M 10-Q · filed 2026-07-31 | $15.11M derived: sum of 3 quarters · filed 2026-07-31 | $17.29M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $9.45M 10-Q · filed 2026-05-06 | $12.72M derived: sum of 2 quarters · filed 2026-05-06 | $14.91M derived: sum of 3 quarters · filed 2026-05-06 | $16.21M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.46M derived: sum of 2 quarters · filed 2026-02-26 | $6.76M derived: sum of 3 quarters · filed 2026-02-26 | $10.59M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.18M 10-Q · filed 2025-11-05 | $3.48M derived: sum of 2 quarters · filed 2025-11-05 | $7.32M 10-Q · filed 2025-11-05 | $8.44M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.30M 10-Q · filed 2025-08-07 | $5.13M 10-Q · filed 2025-08-07 | $6.26M derived: sum of 3 quarters · filed 2026-02-26 | $8.71M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $3.83M 10-Q · filed 2025-05-08 | $4.96M derived: sum of 2 quarters · filed 2026-02-26 | $7.41M derived: sum of 3 quarters · filed 2026-02-26 | $8.29M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.57M derived: sum of 2 quarters · filed 2026-02-26 | $4.46M derived: sum of 3 quarters · filed 2026-02-26 | $6.74M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.45M 10-Q · filed 2024-11-07 | $3.34M derived: sum of 2 quarters · filed 2024-11-07 | $5.61M 10-Q · filed 2024-11-07 | $6.14M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $890.00K 10-Q · filed 2024-08-07 | $3.17M 10-Q · filed 2024-08-07 | $3.69M derived: sum of 3 quarters · filed 2025-02-28 | $4.47M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.28M 10-Q · filed 2024-05-08 | $2.81M derived: sum of 2 quarters · filed 2025-02-28 | $3.58M derived: sum of 3 quarters · filed 2025-02-28 | $4.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $528.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.30M derived: sum of 2 quarters · filed 2025-02-28 | $1.72M derived: sum of 3 quarters · filed 2025-02-28 | $3.17M 10-K · filed 2025-02-28 |
| 2022-09-30 | $773.00K 10-Q · filed 2023-11-08 | $1.19M derived: sum of 2 quarters · filed 2023-11-08 | $2.64M 10-Q · filed 2023-11-08 | $3.36M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $418.00K 10-Q · filed 2023-08-09 | $1.86M 10-Q · filed 2023-08-09 | $2.59M derived: sum of 3 quarters · filed 2024-02-29 | $3.41M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $1.45M 10-Q · filed 2023-05-05 | $2.17M derived: sum of 2 quarters · filed 2024-02-29 | $2.99M derived: sum of 3 quarters · filed 2024-02-29 | $3.70M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $722.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.55M derived: sum of 2 quarters · filed 2024-02-29 | $2.26M derived: sum of 3 quarters · filed 2024-02-29 | $9.03M 10-K · filed 2024-02-29 |
| 2021-09-30 | $824.00K 10-Q · filed 2022-11-03 | $1.53M derived: sum of 2 quarters · filed 2022-11-03 | $8.31M 10-Q · filed 2022-11-03 | $8.99M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $710.00K 10-Q · filed 2022-08-03 | $7.48M 10-Q · filed 2022-08-03 | $8.17M derived: sum of 3 quarters · filed 2023-03-01 | $8.65M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $6.77M 10-Q · filed 2022-05-04 | $7.46M derived: sum of 2 quarters · filed 2023-03-01 | $7.94M derived: sum of 3 quarters · filed 2023-03-01 | $8.31M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.17M derived: sum of 2 quarters · filed 2023-03-01 | $1.54M derived: sum of 3 quarters · filed 2023-03-01 | $3.85M 10-K · filed 2023-03-01 |
| 2020-09-30 | $483.00K 10-Q · filed 2021-11-09 | $857.00K derived: sum of 2 quarters · filed 2021-11-09 | $3.16M 10-Q · filed 2021-11-09 | $3.33M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $374.00K 10-Q · filed 2021-07-29 | $2.68M 10-Q · filed 2021-07-29 | $2.85M derived: sum of 3 quarters · filed 2022-02-28 | $2.98M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $2.30M 10-Q · filed 2021-05-10 | $2.47M derived: sum of 2 quarters · filed 2022-02-28 | $2.60M derived: sum of 3 quarters · filed 2022-02-28 | $2.72M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $299.00K derived: sum of 2 quarters · filed 2022-02-28 | $419.00K derived: sum of 3 quarters · filed 2022-02-28 | $977.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $132.00K 10-Q · filed 2020-11-02 | $252.00K derived: sum of 2 quarters · filed 2020-11-02 | $810.00K 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $120.00K 10-Q · filed 2020-07-30 | $676.00K 10-Q · filed 2020-07-30 | ||
| 2019-03-31 | $556.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $30.00K 10-K · filed 2021-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |